Low-power body device to help diagnose asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new, low-power device worn on the body that may help diagnose asthma. It is for adults who are comfortable using mobile apps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 64 years old.
- You need a smartphone or tablet and basic comfort using apps.
- You must agree to follow the study procedures and sign a consent form.
- You cannot have a known allergy to medical adhesives (like tape or stickers used on the skin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different breathing tests (spirometry and impulse oscillometry) and a simple shortness-of-breath scale relate to how well you respond to a quick-relief inhaler (bronchodilator). It aims to improve how we measure treatment effectiveness in people with asthma or COPD.
This study tests a portable handheld device that measures airway function to help diagnose asthma. Researchers want to see if this device can accurately identify asthma in people with breathing symptoms like wheezing and shortness of breath.
This study tests a new device that measures a lung marker called FeNO (fractional exhaled nitric oxide) to help diagnose asthma. It may be an option for adults with asthma who have not changed their medication recently and have no recent infections.
This trial tests a handheld device that measures nitric oxide in your breath to see if it can help monitor asthma. You may qualify if you have uncontrolled asthma and can use the device at home.
This trial is testing a new breathing device that may be as accurate as standard tests for diagnosing asthma and COPD. It could offer a simpler and quicker way to check your lung health.
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
Hear when a new Asthma Bronchiale trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.